S 3551119th CongressIn Committee
PROTECT for Rare Act
Standard Summary
Balanced plain-English summary
This bill would amend Medicare, Medicaid, and private health insurance rules to improve coverage and appeal rights for drugs used to treat or manage rare diseases or conditions affecting 200,000 or fewer people, including broader medically accepted use standards and expedited appeals for coverage denials.
Key Points
- 1Defines qualifying rare-disease drugs by reference to diseases or conditions affecting 200,000 or fewer individuals in the United States.
- 2Expands Medicare Part B, Medicare Part D, and Medicaid medically accepted indication standards to include peer-reviewed literature and clinical guidelines in certain cases.
- 3Requires group health plans and health insurers to provide an expedited appeal process for denials of coverage for qualifying rare-disease drugs.
- 4Applies the coverage and appeal changes beginning in 2027 for most provisions.
Impact Areas
Rare disease patients and their familiesMedicare and Medicaid beneficiariesPrivate health insurers and group health plansDrug manufacturers and clinicians
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026